DIARRHEA PREVENTION AND PROPHYLAXIS WITH CROFELEMER IN HER2 POSITIVE BREAST CANCER PATIENTS RECEIVING TRASTUZUMAB, PERTUZUMAB, AND DOCETAXEL OR PACLITAXEL WITH OR WITHOUT CARBOPLATIN

May 10, 2018

Type of Cancer

Breast Oncology

Sponsor

Georgetown

Protocol Number

Georgetown2015-0547 HALT-D

To Learn More Call

(201)-510-0950